Stockreport

AEON Biopharma Announces Redemption of Public Warrants

AEON Biopharma, Inc. Class A  (AEON) 
PDF IRVINE, Calif., March 29, 2024 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (NYSE: AEON; AEON.WS) (“AEON” or “the Company”), a clinical-stage biopharmaceutical company foc [Read more]